Latest News for: efficacy
Edit
Ensuring safety and efficacy through the vaccine pipeline
The Hindu 24 Dec 2025
Every vaccine starts its journey years before the first public dose.
Edit
The Facts
24 Dec 2025
Foresee Pharmaceuticals announces the Casppian Phase 3 Study Meets Primary Efficacy Endpoint, Demonstrating Robust LH ...
The proportion of patients with serum luteinizing ...
Edit
Foresee Pharmaceuticals announces the Casppian Phase 3 Study Meets Primary Efficacy Endpoint, Demonstrating Robust LH Suppression with 6-Month Dosing Interval of leuprolide mesylate
PR Newswire 24 Dec 2025
"The consistent safety profile, coupled with the robust efficacy data, strengthens our confidence in FP-001 as a potential best-in-class therapy," added Dr.
Edit
Rio Grande Sun
23 Dec 2025
Promontory Therapeutics Announces Interim Efficacy Requirement Reached on Phase 2 Study of PT-112 Monotherapy in ...
Edit
Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess� in Extremity Trauma Repair
Nasdaq Globe Newswire 22 Dec 2025
- Results published in Journal of Vascular Surgery Cases, Innovations and Techniques (JVS-CIT) -� ... .
Edit
Promontory Therapeutics Announces Interim Efficacy Requirement Reached on Phase 2 Study of PT-112 Monotherapy in Patients with Recurrent Thymoma
PR Newswire 22 Dec 2025
Findings exceed protocol requirement of two responses among first 16 patients evaluated to proceed with stage 2 of efficacy assessment ... After reaching the interim efficacy requirement, enrollment of ...
Edit
The censorship of mask science: How evidence against mask efficacy is being purged
Natural News 19 Dec 2025
Edit
Precision Meets Affordability, Ace Therapeutics Unveils In Vivo Efficacy Testing Services for IBD Drug Candidates
GetNews 19 Dec 2025
Edit
Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients
PR Newswire 18 Dec 2025
Edit
Citizen Tribune
16 Dec 2025
Amorphical Announces Positive Final Long-Term Results from Phase 2 Crohn's Disease Trial: Results Confirm Efficacy ...
Edit
Oncolytics Biotech® Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer
Business Wire 16 Dec 2025
Edit
Latest fungicide performance update includes new products and efficacy warnings (AHDB - UK Agriculture and Horticulture Development Board)
Public Technologies 16 Dec 2025
Edit
Amorphical Announces Positive Final Long-Term Results from Phase 2 Crohn's Disease Trial: Results Confirm Efficacy and Show Sustained Clinical Remission
PR Newswire 16 Dec 2025
Novel Treatment Offers Non-Immunosuppressive Approach for Localized Acid Neutralization and Calcium Delivery. NES ZIONA, Israel, Dec ... Morgan Healthcare Conference in San Francisco this January ... About Amorphical ... SOURCE Amorphical. 21% ... .
Edit
Oncolytics Biotech® Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer (Form 6-K) (Oncolytics Biotech Inc)
Public Technologies 16 Dec 2025
) Oncolytics Biotech® Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer ... SAN DIEGO, CA, December 16, 2025 - Oncolytics Biotech® Inc. (Nasdaq ... Dr ... References.. 1.Bennouna J ... 2.Iwamoto S.
- 1
- 2
- Next page »